# Study on the Applicability of CCR Criteria in Rectal Cancer

> **NCT06794099** · — · COMPLETED · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 177 (actual)

## Conditions studied

- PMMR/MSS Adenocarcinoma of the Colon or Rectum
- Neoadjuvant Chemoradiotherapy
- Immunotherapy
- Complete Response

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06794099
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06794099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06794099, "Study on the Applicability of CCR Criteria in Rectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06794099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*